Although BPC-157 has been proven safe and well-tolerated in clinical trials, there are potential risks such as allergic reactions, interactions with other medications, and unknown long-term effects
Because of this, Ocean Pharmaceutical was not considered to have failed pH
A phase 2b clinical trial was completed in Australia on 300 obese individuals
Status: Early-phase human trials Not commercially available SC injection (research settings) Caveat: Strong mechanistic case
If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly
Baird R, Gholoum S, Laberge J, Puligandla P (2011) Prematurity, not age at operation or incarceration, impacts complication rates of inguinal hernia repair